Automate Your Wheel Strategy on GLPG
With Tiblio's Option Bot, you can configure your own wheel strategy including GLPG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GLPG
- Rev/Share 4.3773
- Book/Share 41.7371
- PB 0.5848
- Debt/Equity 0.004
- CurrentRatio 7.9451
- ROIC -0.0881
- MktCap 1608303312.9352
- FreeCF/Share -4.7406
- PFCF -5.153
- PE -9.4777
- Debt/Assets 0.0027
- DivYield 0
- ROE -0.0594
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | GLPG | Morgan Stanley | Equal Weight | Underweight | $31 | $22 | Feb. 14, 2025 |
| Initiation | GLPG | Leerink Partners | -- | Market Perform | -- | $24 | Sept. 9, 2024 |
News
Galapagos NV (GLPG) Q1 2025 Earnings Call Transcript
Published: April 24, 2025 by: Seeking Alpha
Sentiment: Neutral
Galapagos NV (NASDAQ:GLPG ) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Paul Stoffels - Chair, Chief Executive Officer Thad Huston - Chief Operating, Chief Financial Officer John Mellors - Head of Cell Therapy Discovery WulfBöcher - Head of Immunology Omotayo Fasan - Clinical Program Head, Oncology Valeria Cnossen - Executive and General Counsel Glenn Schulman - Head of Investor Relations Conference Call Participants Brian Abrahams - RBC Capital Markets Phil Nadeau - TD Cowan Sebastiaan van der Schoot - Van Lanschot Kempen Manos Mastorakis - Deutsche Bank Faisal Khurshid - Leerink Partners Judah Frommer …
Read More
Galapagos to Present at Upcoming Investor Conferences
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
Mechelen, Belgium; February 24, 2025, 22:01 CET – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced that its management will present at the following investor conferences in March: TD Cowen 45 th Annual Healthcare Conference Date: Tuesday, March 4, 2025Location: Boston, MACorporate Presentation: 1:50 - 2:20 PM ET / 7:50 - 8:20 PM CETLive Webcast Link: Here Barclays 27 th Annual Global Healthcare Conference Date: Wednesday, March 12, 2025Location: Miami, FLCorporate Presentation: 11:00 - 11:25 AM ET / 5:00 - 5:25 PM CETLive Webcast Link: Here …
Read More
Galapagos receives transparency notification and 13D filing from Tang Capital
Published: February 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang Capital.
Read More
Galapagos NV (GLPG) Q4 2024 Earnings Call Transcript
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Galapagos NV (NASDAQ:GLPG ) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET Company Participants Sri Ramaswami - Senior Vice President and Global Head of Corporate Affairs & Investor Relations Paul Stoffels - Chair of the Board & Chief Executive Officer Thad Huston - Chief Financial Officer & Chief Operating Officer Valeria Cnossen - General Counsel Jeevan Shetty - Head of Clinical Development Oncology John Mellors - Head of Cell Therapy Discovery & Early Development Conference Call Participants Xian Deng - UBS Phil Nadeau - TD Cowen Brian Abrahams - RBC Capital Markets Faisal Khurshid - Leerink Partners …
Read More
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
Published: February 12, 2025 by: GlobeNewsWire
Sentiment: Neutral
Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein
Read More
About Galapagos NV (GLPG)
- IPO Date 2012-02-27
- Website https://www.glpg.com
- Industry Biotechnology
- CEO Mr. Henry Gosebruch
- Employees 704